Dysregulated Protein Phosphorylation in a Mouse Model of FTLD-Tau

dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorAndrés Benito, Pol
dc.contributor.authorAusín, Karina
dc.contributor.authorCartas Cejudo, Paz
dc.contributor.authorLachén Montes, Mercedes
dc.contributor.authorRío Fernández, José Antonio del
dc.contributor.authorFernández Irigoyen, Joaquín
dc.contributor.authorSantamaría, Enrique
dc.date.accessioned2023-03-30T07:22:58Z
dc.date.available2023-07-15T05:10:26Z
dc.date.issued2022-07-15
dc.date.updated2023-03-30T07:22:58Z
dc.description.abstractThe neocortex of P301S mice, used as a model of fronto-temporal lobar degeneration linked to tau mutation (FTLD-tau), and wild-type mice, both aged 9 months, were analyzed with conventional label-free phosphoproteomics and SWATH-MS (sequential window acquisition of all theoretical fragment ion spectra mass spectrometry) to assess the (phospho)proteomes. The total number of identified dysregulated phosphoproteins was 328 corresponding to 524 phosphorylation sites. The majority of dysregulated phosphoproteins, most of them hyperphosphorylated, were proteins of the membranes, synapses, membrane trafficking, membrane vesicles linked to endo- and exocytosis, cytoplasmic vesicles, and cytoskeleton. Another group was composed of kinases. In contrast, proteins linked to DNA, RNA metabolism, RNA splicing, and protein synthesis were hypophosphorylated. Other pathways modulating energy metabolism, cell signaling, Golgi apparatus, carbohydrates, and lipids are also targets of dysregulated protein phosphorylation in P301S mice. The present results, together with accompanying immunohistochemical and Western-blotting studies, show widespread abnormal phosphorylation of proteins, in addition to protein tau, in P301S mice. These observations point to dysregulated protein phosphorylation as a relevant contributory pathogenic component of tauopathies.
dc.format.extent18 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec729257
dc.identifier.issn0022-3069
dc.identifier.urihttps://hdl.handle.net/2445/196240
dc.language.isoeng
dc.publisherLippincott, Williams & Wilkins. Wolters Kluwer Health
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1093/jnen/nlac062
dc.relation.ispartofJournal of Neuropathology and Experimental Neurology, 2022, vol. 81, num. 9, p. 696-706
dc.relation.urihttps://doi.org/10.1093/jnen/nlac062
dc.rights(c) American Association of Neuropathologists, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)
dc.subject.classificationProteòmica
dc.subject.classificationCitosquelet
dc.subject.classificationProteïnes quinases
dc.subject.otherProteomics
dc.subject.otherCytoskeleton
dc.subject.otherProtein kinases
dc.titleDysregulated Protein Phosphorylation in a Mouse Model of FTLD-Tau
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
729257.pdf
Mida:
252.25 KB
Format:
Adobe Portable Document Format